 |
Medical Report for Skin Diseases |
 |
As a young pharmacist in Korea, Jae Sun Shin saw thousands of burn victims from the Korean
War. Frustrated by a lack of adequate burn care products available, he decided to
research this further. A few years later, he began to combine ingredients trying to form a
compound to heal the burn, rather than just treat the burned skin. After many years, he
finally succeeded. In the early 1970’s, he began dispensing his product through his drug
store in Seoul, Korea. This was possible because of the Korean regulations for prescribing
prescriptions. Korea allows a pharmacist to prescribe, prepare, and sell a medicine for a
patient. Originally he gave this medicine out as a burn care product. As people began
using it, he discovered that his product also healed; skin irritations, boils, and especially
ulcerated skin. The U.S. patent was awarded in 1992 and Mr. Shin, the pharmacist, still
prepares this medicine in his drug store for his patients as he has been doing for almost
three decades. What we are trying to accomplish now is to make this wonderful new drug
available to all patients around the world. Who, with modern medicine now, have lost
hope.
The pharmacist, Mr. Shin, has been preparing, selling and witnessing the effectiveness of
this medicine with his own hands for the last 27 years. As any medical personnel will tell
you that currently there is no cure for these problems, only methods of treating and trying
to control. One problem that is especially bad is ulcerated skin. Doctor’s today only have
medicine to treat the problem. Rather than heal it, they just try to control and monitor the
spreading of the problem. As an example, most diabetics who experience skin ulcers. If
the ulcer get to an advanced stage, then the diabetic typically will end up losing a limb or
finger, etc. Because modern medicine today doesn’t heal the problem, they just try and
control the spread of it. With this medication, a diabetic would retain their limb and have
no scars in majority of cases. This medication is a topical cure; it doesn’t require anything
internal. With this medicine, the cost of hospital stays, even doctor visits, would drop
drastically. No more long hospital stays with therapy.
Why is this remarkable medicine not on the front page of all the newspapers? Because of
the typical red tape so thoughtfully provided by the United States government. Winning
FDA approval for a new drug is harder than winning the lottery. We have already been
awarded an U.S. patent for this drug in 1992. We have provided many reports and clinical
results that show the clinical healing power of this medicine. Mr. Shin, the pharmacist,
does not have a tremendous amount of funds or research facilities to perform the tests to
get enough scientific data for the FDA or pharmaceutical companies. Yet the guidelines
are very strict. This drug must be extensively tested by a well-known research facility in
the United States. So, we approached a few U.S. pharmaceutical companies. We met
directly with their research teams, and they have studied our compound. Their medical
personnel evaluated our clinical tests. Both medical and research teams agreed that
indeed, this looks like a very functional product. Though out hopes were raised, they
were quickly dashed. Even thought they liked the product, they would not fund the
research themselves. They suggested we fund the research independently, and have them
conduct it. So this brings us to now.
We are appealing to the conscious of the people. So many people could be helped.
Health care cost would be lowered; medical technology will take a huge leap forward. An
investment in this product would be in an investment in the future and a hope for helpless
patients. Investor’s in this could make a difference in the centuries to come, as well as
today. How often are people given the opportunity to make a change like this? Let me
give you an example of this amazing treatment.
Take a case study such as this:
A little 6-year-old girl is helping Mom cook in the kitchen one day. She accidentally
knocks a pan of boiling water off the stove. She burns the entire length of her left arm.
Her mother rushes her to the hospital, and she is told that her daughter has a second-
degree burn. What she has to look forward to in today’s medical world is about 5 ½
months of treatment, and a lifetime of pain. With a burn like that, the doctor’s will more
than likely opt for a skin graft. So, along with the pain of the burn, and the scar there,
then the little girl also has to deal with a graft. This means that she loses more skin on her
body, to try and make up for the skin lost to the burn. The problem that the little girl
faces then is that grafted skin does not stretch, does not have pores, and does not grow
hair. So, instead of a horrific scar, she now has skin, but it doesn’t look and act normal.
With the product that Mr. Shin has invented, this little girl’s life could be restored to
normal. The new treatment would take approximately 2 weeks. It would require no skin
grafting, and typically it would leave no scar. The major cause of death among burn
patients is not the burn, but rather the complication of infections caused by prolonged
treatment. This treatment is faster and more effective. This is the case with all the
ailments that this treatment cures. It gives new hopes and dreams to patients.
Here’s another example to consider:
A 52-year-old man. He has been a diabetic all his life. He is an avid bicyclist. He has a
bad accident while riding one day, and almost severs his right leg. Because of his diabetes,
the doctor’s cannot prescribe the normal antitoxins available to fight off infection. The
man’s leg becomes infected, and the doctor’s are forced to remove it. The problem with
this cure is that it is not a cure. It is an attempt to control a problem, and it is going to
fail. After they remove his leg, they are faced with the same problem of fighting infection
in his body. They may be able to control it this time, if they can find the right
combinations of antibiotics that will not change the insulin in this man’s bloodstream.
Then again they may not. When diabetics are faced with losing a limb, it can become fatal.
It does not have to be this way. With Mr. Shin’s medicine, this man probably wouldn't
lose his leg. The antibiotics present in this treatment are topical, and therefore wouldn't
alter the level of insulin in the bloodstream. This changes this amputation from a probable
fatality to a short-term treatment. After surviving 52 years, this man needs every chance
that modern day medicine can give him. Without this new treatment, he will not get the
chance he deserves.
Small in comparison to that, would be the opportunity to make a profit on this
investment. The first step we want to take is hiring an institutional research team to
perform an intensive test on this medicine so that we can effectively present the data to
FDA or pharmaceutical companies. Investor’s would be given a share of ownership in this
product. They would have many choices they could make as to how they would take their
profit. It could be in a percentage of royalties, stock in the company, or a realized profit
from a direct sale of the medication to a pharmaceutical company. Whatever the case may
be, there are a multitude of possibilities that exist for an investor in this product, not to
mention a hope to helpless patients.